Surgical Oncology
Volume 19, Issue 1 , Pages e2-e10 , March 2010

Ghrelin's role on gastrointestinal tract cancer

  • Dimitrios Nikolopoulos

      Affiliations

    • 2nd Department of Propedeutic Surgery, University of Athens, Medical School, Laiko General Hospital, Athens, Greece
    • Corresponding Author InformationCorresponding author. Theotokopoulou 29 str, Metamorfosi Attikis, 14452, Greece. Tel.: +30 69 4483 7783; fax: +30 210 777 5354.
    • ,
  • Stamatis Theocharis

      Affiliations

    • Department of Forensic Medicine and Toxicology, University of Athens, Medical School, Athens, Greece
    • ,
  • Gregory Kouraklis

      Affiliations

    • 2nd Department of Propedeutic Surgery, University of Athens, Medical School, Laiko General Hospital, Athens, Greece

,Accepted 14 February 2009.

References 

  1. Momany FA, Bowers CY, Reynolds GA, Chang D, Hong A, Newlander K. Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology. 1981;108(1):31–39[My paper]
  2. Bowers CY. Unnatural growth hormone-releasing peptide begets natural ghrelin. J Clin Endocrinol Metab. 2001;86(4):1464–1469
  3. Rosicka M, Krsek M, Jarkovska Z, Marek J, Schreiber V. Ghrelin – a new endogenous growth hormone secretagogue. Physiol Res. 2002;51:435–441
  4. DRCh Murray, Kamm MA, Bloom SR, Emmanuel AV. Ghrelin for the gasroenterologist: history and potential. Gastroenterology. 2003;125:1492–1502
  5. Kojima M, Hosoda H, Kangawa K. Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide from stomach. Best Pract Res Clin Endocrinol Metab. 2004;18(4):517–530
  6. Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab. 2001;3:118–122
  7. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273:974–977
  8. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–660
  9. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB. Ghrelin—a hormone with multiple functions. Front Neuroendocrinol. 2004;25:27–68
  10. Arvat E, Broglio F, Aimaretti G, Benso A, Giordano R, Deghenghi R, et al. Ghrelin and synthetic GH secretagogues. Best Pract Res Clin Endocrinol Metab. 2002;16(3):505–517
  11. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000;279:909–913
  12. Hosoda H, Kojima M, Mizushima T, Shimizu S, Kangawa K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem. 2003;278:64–70
  13. Banks WA, Tschop M, Robinson SM, Heiman ML. Extent and direction of Ghrelin transport across the blood–brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther. 2002;302:822–827
  14. Bednarek MA, Feighner SD, Pong SS, McKee KK, Hreniuk DL, Silva MV, et al. Structure and function studies on the new growth hormone releasing peptide, ghrelin: minimal sequence of Ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem. 2000;43:4370–4376
  15. Broglio F, Benso A, Gottero C, Prodam F, Gauna C, Filtri L, et al. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans. J Endocrinol Invest. 2003;26:192–196
  16. Bedendi I, Alloatti G, Marcantoni A, Malan D, Catapano F, Ghé C, et al. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln(14)-ghrelin. Eur J Pharmacol. 2003;476:87–95
  17. Cassoni P, Papotti M, Ghe C, Catapano F, Sapino A, Graziani A, et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab. 2001;86:1738–1745
  18. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson ICAF, et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of GHS-R1a. Endocrinology. 2004;145:232–242
  19. Jeffery PL, Herington AC, Chopin LK. The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytok Growth Factor Rev. 2003;14:113–122
  20. Wang HJ, Geller F, Dempfle A, Schäuble N, Friedel S, Lichtner P, et al. Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. J Clin Endocrinol Metab. 2004;89:157–162
  21. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–4261
  22. Dornonville dlC, Bjorkqvist M, Sandvik AK, Bakke I, Zhao CM, Chen D, et al. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept. 2001;99:141–150
  23. Rindi G, Necchi V, Savioet A, Zoli M, Locatelli V, Raimondo F, et al. Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. Histochem Cell Biol. 2002;21:17–24
  24. Kojima M, Kangawa K. Ghrelin, an orexigenic signalling molecule from the gastrointestinal tract. Curr Opin Pharmacol. 2002;2:665–668
  25. Ariyasu H, Takaya K, Tagami T, Yasar A, Colakoglu N, Kelestimur H. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001;86:4753–4758
  26. Krsek M, Rosicka M, Haluzik M, Svobodová J, Kotrlíková E, Justová V, et al. Plasma ghrelin levels in patients with short bowel syndrome. Endocr Res. 2002;28:27–33
  27. Sakata I, Nakamura K, Yamazaki M, Matsubara M, Hayashi Y, Kangawa K, et al. Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides. 2002;23:531–536
  28. Leonetti F, Silecchia G, Iacobellis G, Ribaudo MC, Zappaterreno A, Tiberti C, et al. Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab. 2003;88:4227–4231
  29. Cowley MA, Smith RG, Diano S, Tschöp M, Pronchuk N, Grove KL, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37:649–661
  30. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, et al. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab. 2001;86:881–887
  31. Muccioli G, Ghe C, Ghigo MC, Papotti M, Arvat E, Boghen MF, et al. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J Endocrinol. 1998;157:99–106
  32. Muccioli G, Papotti M, Locatelli V, Ghigo E, Deghenghi R. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J Endocrinol Invest. 2001;24:RC7–RC9
  33. Dixit VM, Schaffer EM, Taub DD. Ghrelin is expressed and secreted from human T lymphocytes and inhibits activation and leptin induced inflammatory cytokine expression via functional, lipid raft-associated growth hormone secretagogue receptors (GHS-R): Proceedings of the 85th Annual Meeting of the Endocrine Society 2003; OR51–OR53.
  34. Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab. 2001;86:4284–4291
  35. Volante M, Fulcheri E, Allia E, Cerrato M, Pucci A, Papotti M. Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem. 2002;50:1013–1021
  36. Gualillo O, Caminos JE, Blanco M, Garcìa-Caballero T, Kojima M, Kangawa K, et al. Ghrelin, a novel placental-derived hormone. Endocrinology. 2001;142:788–794
  37. Caminos JE, Tena-Sempere M, Gaytan F, Sanchez-Criado JE, Barreiro ML, Nogueiras R, et al. Expression of ghrelin in the cyclic and pregnant rat ovary. Endocrinology. 2003;144:1594–1602
  38. Gaytan F, Barreiro ML, Chopin LK, Herington AC, Morales C, Pinilla L, et al. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor in the cyclic human ovary. J Clin Endocrinol Metab. 2003;88:879–887
  39. Barreiro ML, Gaytan F, Caminos JE, Pinilla L, Casanueva FF, Aguilar E, et al. Cellular location and hormonal regulation of ghrelin expression in rat testis. Biol Reprod. 2002;67:1768–1776
  40. Tena-Sempere M, Barreiro ML, Gonzalez LC, Gaytán F, Zhang FP, Caminos JE, et al. Novel expression and functional role of ghrelin in rat testis. Endocrinology. 2002;143:717–725
  41. Volante M, Allia E, Gugliotta P, Funaro A, Broglio F, Deghenghi R, et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab. 2002;87:1300–1308
  42. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes. 2002;51:124–129
  43. Prado CL, Pugh-Bernard AE, Elghazi L, Sosa-Pineda B, Sussel L. Ghrelin cells replace insulin-producing {beta} cells in two mouse models of pancreas development. Proc Natl Acad Sci USA. 2004;101:2924–2929
  44. Wierup N, Svensson H, Mulder H, Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept. 2002;107:63–69
  45. Kim K, Arai K, Sannot N, Osamura RY, Teramoto A, Shibasaki T. Ghrelin and GHSR mRNA expression in human pituitary adenomas. Clin Endocrin. 2001;54:759–768
  46. Nanzer AM, Khalaf S, Mozid AM, Fowkes RC, Patel MV, Burrin JM, et al. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur J Endocrinol. 2004;151:233–240
  47. Cassoni P, Papotti M, Catapano F, Ghè C, Deghenghi R, Ghigo E, et al. Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue. J Endocrinol. 2000;165:139–146
  48. Volante M, Allia E, Fulcheri E, Cassoni P, Ghigo E, Muccioli G, et al. Ghrelin in fetal thyroid and follicular tumors and cell lines. Am J Pathol. 2003;162(2):645–654
  49. Ghe C, Cassoni P, Catapano F, Marrocco T, Deghenghi R, Ghigo E, et al. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology. 2002;143:484–491
  50. Cassoni P, Ghe C, Marrocco T, Tarabra E, Allia E, Catapano F, et al. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrin. 2004;150:173–184
  51. Jeffery PL, Murray RE, Yeh AH, McNamara JF, Duncan RP, Francis GD, et al. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer. 2005;12:839–850
  52. Jeffery PL, Herington AC, Chopin LK. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol. 2002;172:R7–R11
  53. Yeh AH, Jeffery PL, Duncan RP, Herington AC, Chopin LK. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res. 2005;11(23):8295–8303
  54. Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, et al. Ghrelin modulates the downstream of insulin signaling in hepatoma cells. J Biol Chem. 2002;277:5667–5674
  55. Duxbury MS, Waseem T, Ito H, Robinson MK, Zinner MJ, Ashley SW, et al. Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem Biophys Res Commun. 2003;309:464–468
  56. Arnaldi G, Mancini T, Kola B, Appolloni G, Freddi S, Concettoni C, et al. Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. J Clin Endocrinol Metab. 2003;88(12):5834–58405834–40
  57. Delhanty PJD, van Koetsveld PM, Gauna C, van de Zande B, Vitale G, Hofland LJ, et al. Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway. Am J Physiol Endocrinol Metab. 2007;293:E302–E309
  58. Papotti M, Cassoni P, Volante M, Deghenghi R, Muccioli G, Ghigo E. Ghrelin-producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab. 2001;86:5052–5059
  59. Iwakura H, Hosoda K, Doi R, Komoto I, Nishimura H, Son C, et al. Ghrelin expression in islet cell tumors: augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm type I. J Clin Endocrinol Metab. 2002;87:4885–4888
  60. Ekeblad S, Lejonklou MH, Grimfjard P, Johansson T, Eriksoon B, Grimelius L, et al. Co-expression of ghrelin and its receptor in pancreatic endocrine tumours. Clin Endocrinol. 2007;66:115–122
  61. Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herington AC, Morales C, et al. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab. 2004;89:400–409
  62. Dixit VD, Weeraratna AT, Yang H, Bertak D, Cooper-Jenkins A, Riggins GJ, et al. Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility. J Biol Chem. 2006;281(24):16681–16690
  63. Puduvalli VK, Kyritsis AP, Hess KR, Bondy ML, Fuller GN, Kouraklis GP, et al. Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival. Int J Oncol. 2000;17(5):963–969
  64. de Herder WW. Biochemistry of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab. 2007;21(1):33–41
  65. Leontiou CA, Franchi G, Korbonits M. Ghrelin in neuroendocrine organs and tumours. Pituitary. 2007;10:213–225
  66. Kojima K, Miyake M, Nakagawa H, Yunoki Y, Ogurusu K, Saino S, et al. Multiple gastric carcinoids and pituitary adenoma in type A gastritis. Intern Med. 1997;36:787–789
  67. Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology. 1999;116:532–542
  68. Tsolakis A, Portella-Gomes GM, Stridsberg M, Grimelius L, Sundin A, Eriksson BK, et al. Malignant gastric ghrelinoma with hyperghrelinemia. J Clin Endocrinol Metab. 2004;89(8):3739–3744
  69. Aydin S, Ozercan IH, Dagli F, Aydin S, Dogru O, Celebi S, et al. Ghrelin immunohistochemistry of gastric adenocarcinoma and mucoepidermoid carcinoma of salivary gland. Biotech Histochem. 2005;80(3-4):163–168
  70. Huang Q, Fan Y-Z, Ge B-J, Zhu Q, Tu Z-Y. Circulating ghrelin in patients with gastric or colorectal cancer. Dig Dis Sci. 2007;52:803–809
  71. Ji YA, Min-Gew Ch, Jae HN, Sohn TS, Jin DK, Kim S. Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. J Surg Res. 2007;143:344–349
  72. D'Onghia V, Leoncini R, Carli R, Santoro A, Giglioni S, Sorbellini F, et al. Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI. Biomed Pharmacother. 2007;61:137–141
  73. Mottershead M, Karteris E, Barclay JY, Suortamo S, Newbold M, Randeva H, et al. Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinomas. J Clin Pathol. 2007;60:405–409
  74. Waseem T, Javaid-ur- Rehman, Ahmad F, Azam M, Qureshi AM. Role of ghrelin axis in colorectal cancer: a novel association. Peptides. 2008;29:1369–1376

PII: S0960-7404(09)00033-4

doi: 10.1016/j.suronc.2009.02.011

Surgical Oncology
Volume 19, Issue 1 , Pages e2-e10 , March 2010

Article Tools